Rate My Professor Benjamin Ewald

Ewald's research focuses on diagnostic test accuracy in general practice, including ambulatory blood pressure monitoring and B-type natriuretic peptide for heart failure. He has contributed to community-based physical activity studies and leads a randomized controlled trial on physical activity promotion initiated in 2011. Additional interests include public health advocacy for activity-promoting environments, environmental health risks, accelerometer data analysis for physical activity, integration of objective measures into clinical practice, and health system data analysis for cycling safety. He has authored chapters such as "Climate Change and Human Health" (2022) and "B-type natriuretic peptide: A new diagnostic tool for congestive heart failure" (2011), along with numerous journal articles, including "Health risks from indoor gas appliances" (2022), and conference papers on physical activity dose-response and general practice waiting room studies. Ewald has secured grants exceeding $1.3 million, notably an NHMRC project on exercise physiologist counseling efficacy ($896,589, 2011-2013).